205 related articles for article (PubMed ID: 21049985)
1. Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain.
Liao WL; Heo GY; Dodder NG; Reem RE; Mast N; Huang S; Dipatre PL; Turko IV; Pikuleva IA
J Proteome Res; 2011 Jan; 10(1):241-8. PubMed ID: 21049985
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 27A1 Deficiency and Regional Differences in Brain Sterol Metabolism Cause Preferential Cholestanol Accumulation in the Cerebellum.
Mast N; Anderson KW; Lin JB; Li Y; Turko IV; Tatsuoka C; Bjorkhem I; Pikuleva IA
J Biol Chem; 2017 Mar; 292(12):4913-4924. PubMed ID: 28190002
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol-metabolizing cytochromes P450.
Pikuleva IA
Drug Metab Dispos; 2006 Apr; 34(4):513-20. PubMed ID: 16434543
[TBL] [Abstract][Full Text] [Related]
4. Retinal and nonocular abnormalities in Cyp27a1(-/-)Cyp46a1(-/-) mice with dysfunctional metabolism of cholesterol.
Saadane A; Mast N; Charvet CD; Omarova S; Zheng W; Huang SS; Kern TS; Peachey NS; Pikuleva IA
Am J Pathol; 2014 Sep; 184(9):2403-19. PubMed ID: 25065682
[TBL] [Abstract][Full Text] [Related]
5. Isolevuglandins and mitochondrial enzymes in the retina: mass spectrometry detection of post-translational modification of sterol-metabolizing CYP27A1.
Charvet C; Liao WL; Heo GY; Laird J; Salomon RG; Turko IV; Pikuleva IA
J Biol Chem; 2011 Jun; 286(23):20413-22. PubMed ID: 21498512
[TBL] [Abstract][Full Text] [Related]
6. Marked change in the balance between CYP27A1 and CYP46A1 mediated elimination of cholesterol during differentiation of human neuronal cells.
Milagre I; Olin M; Nunes MJ; Moutinho M; Lövgren-Sandblom A; Gama MJ; Björkhem I; Rodrigues E
Neurochem Int; 2012 Jan; 60(2):192-8. PubMed ID: 22185844
[TBL] [Abstract][Full Text] [Related]
7. Cholestenoic Acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain.
Mast N; Reem R; Bederman I; Huang S; DiPatre PL; Bjorkhem I; Pikuleva IA
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):594-603. PubMed ID: 20881306
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of cholesterol hydroxylases in Alzheimer's disease.
Brown J; Theisler C; Silberman S; Magnuson D; Gottardi-Littell N; Lee JM; Yager D; Crowley J; Sambamurti K; Rahman MM; Reiss AB; Eckman CB; Wolozin B
J Biol Chem; 2004 Aug; 279(33):34674-81. PubMed ID: 15148325
[TBL] [Abstract][Full Text] [Related]
9. The Interplay between Retinal Pathways of Cholesterol Output and Its Effects on Mouse Retina.
Petrov AM; Astafev AA; Mast N; Saadane A; El-Darzi N; Pikuleva IA
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31842366
[TBL] [Abstract][Full Text] [Related]
10. Features of the retinal environment which affect the activities and product profile of cholesterol-metabolizing cytochromes P450 CYP27A1 and CYP11A1.
Heo GY; Liao WL; Turko IV; Pikuleva IA
Arch Biochem Biophys; 2012 Feb; 518(2):119-26. PubMed ID: 22227097
[TBL] [Abstract][Full Text] [Related]
11. 24S-hydroxycholesterol and cholesterol-24S-hydroxylase (CYP46A1) in the retina: from cholesterol homeostasis to pathophysiology of glaucoma.
Fourgeux C; Bron A; Acar N; Creuzot-Garcher C; Bretillon L
Chem Phys Lipids; 2011 Sep; 164(6):496-9. PubMed ID: 21531213
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina.
Bretillon L; Diczfalusy U; Björkhem I; Maire MA; Martine L; Joffre C; Acar N; Bron A; Creuzot-Garcher C
Curr Eye Res; 2007 Apr; 32(4):361-6. PubMed ID: 17453958
[TBL] [Abstract][Full Text] [Related]
13. Combined use of mass spectrometry and heterologous expression for identification of membrane-interacting peptides in cytochrome P450 46A1 and NADPH-cytochrome P450 oxidoreductase.
Mast N; Liao WL; Pikuleva IA; Turko IV
Arch Biochem Biophys; 2009 Mar; 483(1):81-9. PubMed ID: 19161969
[TBL] [Abstract][Full Text] [Related]
14. Retinal Vascular Abnormalities and Microglia Activation in Mice with Deficiency in Cytochrome P450 46A1-Mediated Cholesterol Removal.
Saadane A; Mast N; Trichonas G; Chakraborty D; Hammer S; Busik JV; Grant MB; Pikuleva IA
Am J Pathol; 2019 Feb; 189(2):405-425. PubMed ID: 30448403
[TBL] [Abstract][Full Text] [Related]
15. The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo.
Shafaati M; Mast N; Beck O; Nayef R; Heo GY; Björkhem-Bergman L; Lütjohann D; Björkhem I; Pikuleva IA
J Lipid Res; 2010 Feb; 51(2):318-23. PubMed ID: 19474457
[TBL] [Abstract][Full Text] [Related]
16. Antifungal Azoles: Structural Insights into Undesired Tight Binding to Cholesterol-Metabolizing CYP46A1.
Mast N; Zheng W; Stout CD; Pikuleva IA
Mol Pharmacol; 2013 Jul; 84(1):86-94. PubMed ID: 23604141
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (CYP27A1).
von Bahr S; Movin T; Papadogiannakis N; Pikuleva I; Rönnow P; Diczfalusy U; Björkhem I
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1129-35. PubMed ID: 12117727
[TBL] [Abstract][Full Text] [Related]
18. Sample prefractionation for mass spectrometry quantification of low-abundance membrane proteins.
Wang M; Heo GY; Omarova S; Pikuleva IA; Turko IV
Anal Chem; 2012 Jun; 84(12):5186-91. PubMed ID: 22607469
[TBL] [Abstract][Full Text] [Related]
19. In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina.
Fourgeux C; Martine L; Acar N; Bron AM; Creuzot-Garcher CP; Bretillon L
Biochem Biophys Res Commun; 2014 Apr; 446(3):775-81. PubMed ID: 24491555
[TBL] [Abstract][Full Text] [Related]
20. Increased Levels of 27-Hydroxycholesterol Induced by Dietary Cholesterol in Brain Contribute to Learning and Memory Impairment in Rats.
Zhang X; Lv C; An Y; Liu Q; Rong H; Tao L; Wang Y; Wang Y; Xiao R
Mol Nutr Food Res; 2018 Feb; 62(3):. PubMed ID: 29193679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
